Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1999-01-29

AUTHORS

P Lenner, F Wiklund, S O Emdin, C Arnerlöv, C Eklund, G Hallmans, H Zentgraf, J Dillner

ABSTRACT

To perform an epidemiological evaluation of the predictive value of p53 autoantibodies in breast cancer, we measured antibodies against p53 in serum samples from 165 breast cancer patients in comparison with serum samples from 330 healthy controls, selected from the same population as the cases and matched for age, sex and specimen storage time. Median age of patients was 51 years (range 25–64 years). Presence of serum p53 autoantibodies was analysed by enzyme-linked immunosorbent assay (ELISA) and confirmed by Western blotting. The lower ELISA reactivities were similar for cases and controls, but presence of high-level reactivity was more common among cases than among controls [odds ratio (OR) 9.03, 95% confidence interval (CI) 2.40–50.43]. Presence of Western blot-detected p53 autoantibodies had a very similar association (OR 10.8, CI 3.0–59.4). Among the cases, we also studied whether there was any correlation between level of anti-p53 antibodies and stage of the disease or survival. There was no significant correlation between presence of antibodies and stage of the disease. There was a significant negative correlation between presence of p53 antibodies and survival (P= 0.003). A stepwise multivariate Cox regression analysis showed that T-stage, age and presence of anti-p53 antibodies were significant independent prognostic variables, with a dose-dependent negative effect on survival for all three variables. We conclude that presence of anti-p53 antibodies are of significance both for the risk of having breast cancer and the risk of dying from breast cancer. More... »

PAGES

927-932

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6690148

DOI

http://dx.doi.org/10.1038/sj.bjc.6690148

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026776861

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10070892


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoantibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme-Linked Immunosorbent Assay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sweden", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Department of Oncology, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lenner", 
        "givenName": "P", 
        "id": "sg:person.0721051037.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721051037.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Department of Oncology, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wiklund", 
        "givenName": "F", 
        "id": "sg:person.0620136570.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620136570.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Department of Surgery, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Emdin", 
        "givenName": "S O", 
        "id": "sg:person.0753001737.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753001737.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Department of Surgery, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arnerl\u00f6v", 
        "givenName": "C", 
        "id": "sg:person.01320724423.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320724423.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Microbiology and Tumor Biology Center, Karolinska Institute, S-17177, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Microbiology and Tumor Biology Center, Karolinska Institute, S-17177, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eklund", 
        "givenName": "C", 
        "id": "sg:person.01016527507.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016527507.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Department of Pathology, Ume\u00e5 University, S-901 85, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hallmans", 
        "givenName": "G", 
        "id": "sg:person.01023564410.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023564410.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Applied Tumor Virology, German Cancer Research Center, D-69009, Heidelberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Applied Tumor Virology, German Cancer Research Center, D-69009, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zentgraf", 
        "givenName": "H", 
        "id": "sg:person.01344140443.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344140443.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Microbiology and Tumor Biology Center, Karolinska Institute, S-17177, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Microbiology and Tumor Biology Center, Karolinska Institute, S-17177, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dillner", 
        "givenName": "J", 
        "id": "sg:person.01254603055.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254603055.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1994.219", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015165622", 
          "https://doi.org/10.1038/bjc.1994.219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.242", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014740554", 
          "https://doi.org/10.1038/bjc.1995.242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039255838", 
          "https://doi.org/10.1038/bjc.1995.386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01209124", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040767935", 
          "https://doi.org/10.1007/bf01209124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00683198", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006247401", 
          "https://doi.org/10.1007/bf00683198"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-01-29", 
    "datePublishedReg": "1999-01-29", 
    "description": "To perform an epidemiological evaluation of the predictive value of p53 autoantibodies in breast cancer, we measured antibodies against p53 in serum samples from 165 breast cancer patients in comparison with serum samples from 330 healthy controls, selected from the same population as the cases and matched for age, sex and specimen storage time. Median age of patients was 51 years (range 25\u201364 years). Presence of serum p53 autoantibodies was analysed by enzyme-linked immunosorbent assay (ELISA) and confirmed by Western blotting. The lower ELISA reactivities were similar for cases and controls, but presence of high-level reactivity was more common among cases than among controls [odds ratio (OR) 9.03, 95% confidence interval (CI) 2.40\u201350.43]. Presence of Western blot-detected p53 autoantibodies had a very similar association (OR 10.8, CI 3.0\u201359.4). Among the cases, we also studied whether there was any correlation between level of anti-p53 antibodies and stage of the disease or survival. There was no significant correlation between presence of antibodies and stage of the disease. There was a significant negative correlation between presence of p53 antibodies and survival (P= 0.003). A stepwise multivariate Cox regression analysis showed that T-stage, age and presence of anti-p53 antibodies were significant independent prognostic variables, with a dose-dependent negative effect on survival for all three variables. We conclude that presence of anti-p53 antibodies are of significance both for the risk of having breast cancer and the risk of dying from breast cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6690148", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5-6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "79"
      }
    ], 
    "keywords": [
      "anti-p53 antibodies", 
      "p53 autoantibodies", 
      "breast cancer", 
      "enzyme-linked immunosorbent assay", 
      "stepwise multivariate Cox regression analysis", 
      "significant independent prognostic variables", 
      "multivariate Cox regression analysis", 
      "population-based epidemiological study", 
      "serum samples", 
      "serum p53 autoantibodies", 
      "Cox regression analysis", 
      "breast cancer patients", 
      "independent prognostic variables", 
      "presence of antibodies", 
      "dose-dependent negative effect", 
      "lower ELISA reactivity", 
      "high-level reactivity", 
      "median age", 
      "T stage", 
      "epidemiological evaluation", 
      "cancer patients", 
      "specimen storage time", 
      "serum antibodies", 
      "healthy controls", 
      "p53 antibodies", 
      "prognostic variables", 
      "cancer risk", 
      "epidemiological studies", 
      "predictive value", 
      "similar association", 
      "significant negative correlation", 
      "ELISA reactivity", 
      "autoantibodies", 
      "cancer", 
      "Western blotting", 
      "immunosorbent assay", 
      "antibodies", 
      "patients", 
      "significant correlation", 
      "regression analysis", 
      "survival", 
      "age", 
      "disease", 
      "risk", 
      "p53", 
      "negative correlation", 
      "same population", 
      "prognosis", 
      "cases", 
      "control", 
      "blotting", 
      "sex", 
      "correlation", 
      "presence", 
      "association", 
      "assays", 
      "population", 
      "years", 
      "reactivity", 
      "stage", 
      "samples", 
      "levels", 
      "negative effects", 
      "evaluation", 
      "significance", 
      "variables", 
      "study", 
      "effect", 
      "time", 
      "comparison", 
      "analysis", 
      "storage time", 
      "values", 
      "relation"
    ], 
    "name": "Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study", 
    "pagination": "927-932", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026776861"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6690148"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10070892"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6690148", 
      "https://app.dimensions.ai/details/publication/pub.1026776861"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_344.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6690148"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690148'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690148'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690148'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690148'


 

This table displays all metadata directly associated to this object as RDF triples.

282 TRIPLES      21 PREDICATES      121 URIs      108 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6690148 schema:about N12f57bc0191b4847a1bdff77ce8457d3
2 N21be0407a71d492998099019b72858e3
3 N286c6562dd0b416e9dc1eb1ec37617ff
4 N3cd82b80db4541338d5bc9b3c36996f4
5 N485ee2749e2a468e8b26deb8e6966e93
6 N4ff80012ec7b49d3ba57a37bb365e5e5
7 N617f1421c41c4ba9bfc953ded58a9a60
8 N6b847176ba824378bd9a62d401a67305
9 N783cebbce2d7410ebaab4089aaaa4b18
10 N881d7091591e41708b629b15a0c88ba6
11 N933e44b9728d465d9d5e8b0e4fb36c77
12 Na77d2c13305548239ad69752c8e349a4
13 Nb7705161247443e6b71a17a3872e62a8
14 Nc02e08fec8aa4f2faf8cd9c3f1a5ec6e
15 Nd0562481e97a4b2398b5125d7397ebc6
16 Ne977ad67d2f941139a9d6a29efc34a6d
17 Nfde2f562d88e4f9bb12ce6a7d604199a
18 anzsrc-for:11
19 anzsrc-for:1112
20 schema:author N3b422b325a49466d84a3e795f73e3e71
21 schema:citation sg:pub.10.1007/bf00683198
22 sg:pub.10.1007/bf01209124
23 sg:pub.10.1038/bjc.1994.219
24 sg:pub.10.1038/bjc.1995.242
25 sg:pub.10.1038/bjc.1995.386
26 schema:datePublished 1999-01-29
27 schema:datePublishedReg 1999-01-29
28 schema:description To perform an epidemiological evaluation of the predictive value of p53 autoantibodies in breast cancer, we measured antibodies against p53 in serum samples from 165 breast cancer patients in comparison with serum samples from 330 healthy controls, selected from the same population as the cases and matched for age, sex and specimen storage time. Median age of patients was 51 years (range 25–64 years). Presence of serum p53 autoantibodies was analysed by enzyme-linked immunosorbent assay (ELISA) and confirmed by Western blotting. The lower ELISA reactivities were similar for cases and controls, but presence of high-level reactivity was more common among cases than among controls [odds ratio (OR) 9.03, 95% confidence interval (CI) 2.40–50.43]. Presence of Western blot-detected p53 autoantibodies had a very similar association (OR 10.8, CI 3.0–59.4). Among the cases, we also studied whether there was any correlation between level of anti-p53 antibodies and stage of the disease or survival. There was no significant correlation between presence of antibodies and stage of the disease. There was a significant negative correlation between presence of p53 antibodies and survival (P= 0.003). A stepwise multivariate Cox regression analysis showed that T-stage, age and presence of anti-p53 antibodies were significant independent prognostic variables, with a dose-dependent negative effect on survival for all three variables. We conclude that presence of anti-p53 antibodies are of significance both for the risk of having breast cancer and the risk of dying from breast cancer.
29 schema:genre article
30 schema:isAccessibleForFree true
31 schema:isPartOf N02d30859f1a041b3b91810af992d4766
32 N737e95e3cff743c4882bc9b653a86493
33 sg:journal.1017082
34 schema:keywords Cox regression analysis
35 ELISA reactivity
36 T stage
37 Western blotting
38 age
39 analysis
40 anti-p53 antibodies
41 antibodies
42 assays
43 association
44 autoantibodies
45 blotting
46 breast cancer
47 breast cancer patients
48 cancer
49 cancer patients
50 cancer risk
51 cases
52 comparison
53 control
54 correlation
55 disease
56 dose-dependent negative effect
57 effect
58 enzyme-linked immunosorbent assay
59 epidemiological evaluation
60 epidemiological studies
61 evaluation
62 healthy controls
63 high-level reactivity
64 immunosorbent assay
65 independent prognostic variables
66 levels
67 lower ELISA reactivity
68 median age
69 multivariate Cox regression analysis
70 negative correlation
71 negative effects
72 p53
73 p53 antibodies
74 p53 autoantibodies
75 patients
76 population
77 population-based epidemiological study
78 predictive value
79 presence
80 presence of antibodies
81 prognosis
82 prognostic variables
83 reactivity
84 regression analysis
85 relation
86 risk
87 same population
88 samples
89 serum antibodies
90 serum p53 autoantibodies
91 serum samples
92 sex
93 significance
94 significant correlation
95 significant independent prognostic variables
96 significant negative correlation
97 similar association
98 specimen storage time
99 stage
100 stepwise multivariate Cox regression analysis
101 storage time
102 study
103 survival
104 time
105 values
106 variables
107 years
108 schema:name Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
109 schema:pagination 927-932
110 schema:productId N58175522d7d548eb82057c7089eeb469
111 N994768ded99c4644a716d9ed3f6b288d
112 Neaa8cd584c4243b6baa275b103dfadbf
113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026776861
114 https://doi.org/10.1038/sj.bjc.6690148
115 schema:sdDatePublished 2022-10-01T06:31
116 schema:sdLicense https://scigraph.springernature.com/explorer/license/
117 schema:sdPublisher Nff9223f0fde446ec876d8616d31c0c39
118 schema:url https://doi.org/10.1038/sj.bjc.6690148
119 sgo:license sg:explorer/license/
120 sgo:sdDataset articles
121 rdf:type schema:ScholarlyArticle
122 N02d30859f1a041b3b91810af992d4766 schema:volumeNumber 79
123 rdf:type schema:PublicationVolume
124 N12f57bc0191b4847a1bdff77ce8457d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Middle Aged
126 rdf:type schema:DefinedTerm
127 N1853e138321248a6baf032a63f8c7fbc rdf:first sg:person.01254603055.20
128 rdf:rest rdf:nil
129 N21be0407a71d492998099019b72858e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Prognosis
131 rdf:type schema:DefinedTerm
132 N286c6562dd0b416e9dc1eb1ec37617ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Adult
134 rdf:type schema:DefinedTerm
135 N3365526e7aa0406b91767542c53b5489 rdf:first sg:person.0620136570.19
136 rdf:rest N7ab55a95cbc94e72868d3c4c33e287c0
137 N3b422b325a49466d84a3e795f73e3e71 rdf:first sg:person.0721051037.52
138 rdf:rest N3365526e7aa0406b91767542c53b5489
139 N3cd82b80db4541338d5bc9b3c36996f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Tumor Suppressor Protein p53
141 rdf:type schema:DefinedTerm
142 N3cfa8c6c2238429392d781804bbf8047 rdf:first sg:person.01344140443.18
143 rdf:rest N1853e138321248a6baf032a63f8c7fbc
144 N485ee2749e2a468e8b26deb8e6966e93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Risk Assessment
146 rdf:type schema:DefinedTerm
147 N4ff80012ec7b49d3ba57a37bb365e5e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Sweden
149 rdf:type schema:DefinedTerm
150 N58175522d7d548eb82057c7089eeb469 schema:name pubmed_id
151 schema:value 10070892
152 rdf:type schema:PropertyValue
153 N617f1421c41c4ba9bfc953ded58a9a60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Female
155 rdf:type schema:DefinedTerm
156 N624790550c6a4d72b3a25feacd419636 rdf:first sg:person.01016527507.51
157 rdf:rest Nff8b1254a8d44a42a2ae8f59b39957a8
158 N6b847176ba824378bd9a62d401a67305 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Neoplasm Staging
160 rdf:type schema:DefinedTerm
161 N737e95e3cff743c4882bc9b653a86493 schema:issueNumber 5-6
162 rdf:type schema:PublicationIssue
163 N783cebbce2d7410ebaab4089aaaa4b18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Case-Control Studies
165 rdf:type schema:DefinedTerm
166 N7ab55a95cbc94e72868d3c4c33e287c0 rdf:first sg:person.0753001737.24
167 rdf:rest Nda5b2c7dc4bc48f097ce9048a9895629
168 N881d7091591e41708b629b15a0c88ba6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Enzyme-Linked Immunosorbent Assay
170 rdf:type schema:DefinedTerm
171 N933e44b9728d465d9d5e8b0e4fb36c77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Survival Analysis
173 rdf:type schema:DefinedTerm
174 N994768ded99c4644a716d9ed3f6b288d schema:name dimensions_id
175 schema:value pub.1026776861
176 rdf:type schema:PropertyValue
177 Na77d2c13305548239ad69752c8e349a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Risk Factors
179 rdf:type schema:DefinedTerm
180 Nb7705161247443e6b71a17a3872e62a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Time Factors
182 rdf:type schema:DefinedTerm
183 Nc02e08fec8aa4f2faf8cd9c3f1a5ec6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Follow-Up Studies
185 rdf:type schema:DefinedTerm
186 Nd0562481e97a4b2398b5125d7397ebc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Humans
188 rdf:type schema:DefinedTerm
189 Nda5b2c7dc4bc48f097ce9048a9895629 rdf:first sg:person.01320724423.15
190 rdf:rest N624790550c6a4d72b3a25feacd419636
191 Ne977ad67d2f941139a9d6a29efc34a6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Autoantibodies
193 rdf:type schema:DefinedTerm
194 Neaa8cd584c4243b6baa275b103dfadbf schema:name doi
195 schema:value 10.1038/sj.bjc.6690148
196 rdf:type schema:PropertyValue
197 Nfde2f562d88e4f9bb12ce6a7d604199a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Breast Neoplasms
199 rdf:type schema:DefinedTerm
200 Nff8b1254a8d44a42a2ae8f59b39957a8 rdf:first sg:person.01023564410.54
201 rdf:rest N3cfa8c6c2238429392d781804bbf8047
202 Nff9223f0fde446ec876d8616d31c0c39 schema:name Springer Nature - SN SciGraph project
203 rdf:type schema:Organization
204 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
205 schema:name Medical and Health Sciences
206 rdf:type schema:DefinedTerm
207 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
208 schema:name Oncology and Carcinogenesis
209 rdf:type schema:DefinedTerm
210 sg:journal.1017082 schema:issn 0007-0920
211 1532-1827
212 schema:name British Journal of Cancer
213 schema:publisher Springer Nature
214 rdf:type schema:Periodical
215 sg:person.01016527507.51 schema:affiliation grid-institutes:grid.4714.6
216 schema:familyName Eklund
217 schema:givenName C
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016527507.51
219 rdf:type schema:Person
220 sg:person.01023564410.54 schema:affiliation grid-institutes:grid.12650.30
221 schema:familyName Hallmans
222 schema:givenName G
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023564410.54
224 rdf:type schema:Person
225 sg:person.01254603055.20 schema:affiliation grid-institutes:grid.4714.6
226 schema:familyName Dillner
227 schema:givenName J
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254603055.20
229 rdf:type schema:Person
230 sg:person.01320724423.15 schema:affiliation grid-institutes:grid.12650.30
231 schema:familyName Arnerlöv
232 schema:givenName C
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320724423.15
234 rdf:type schema:Person
235 sg:person.01344140443.18 schema:affiliation grid-institutes:grid.7497.d
236 schema:familyName Zentgraf
237 schema:givenName H
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344140443.18
239 rdf:type schema:Person
240 sg:person.0620136570.19 schema:affiliation grid-institutes:grid.12650.30
241 schema:familyName Wiklund
242 schema:givenName F
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620136570.19
244 rdf:type schema:Person
245 sg:person.0721051037.52 schema:affiliation grid-institutes:grid.12650.30
246 schema:familyName Lenner
247 schema:givenName P
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721051037.52
249 rdf:type schema:Person
250 sg:person.0753001737.24 schema:affiliation grid-institutes:grid.12650.30
251 schema:familyName Emdin
252 schema:givenName S O
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753001737.24
254 rdf:type schema:Person
255 sg:pub.10.1007/bf00683198 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006247401
256 https://doi.org/10.1007/bf00683198
257 rdf:type schema:CreativeWork
258 sg:pub.10.1007/bf01209124 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040767935
259 https://doi.org/10.1007/bf01209124
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/bjc.1994.219 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015165622
262 https://doi.org/10.1038/bjc.1994.219
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/bjc.1995.242 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014740554
265 https://doi.org/10.1038/bjc.1995.242
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/bjc.1995.386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039255838
268 https://doi.org/10.1038/bjc.1995.386
269 rdf:type schema:CreativeWork
270 grid-institutes:grid.12650.30 schema:alternateName Department of Oncology, Umeå University, S-901 85, Umeå, Sweden
271 Department of Pathology, Umeå University, S-901 85, Umeå, Sweden
272 Department of Surgery, Umeå University, S-901 85, Umeå, Sweden
273 schema:name Department of Oncology, Umeå University, S-901 85, Umeå, Sweden
274 Department of Pathology, Umeå University, S-901 85, Umeå, Sweden
275 Department of Surgery, Umeå University, S-901 85, Umeå, Sweden
276 rdf:type schema:Organization
277 grid-institutes:grid.4714.6 schema:alternateName Microbiology and Tumor Biology Center, Karolinska Institute, S-17177, Stockholm, Sweden
278 schema:name Microbiology and Tumor Biology Center, Karolinska Institute, S-17177, Stockholm, Sweden
279 rdf:type schema:Organization
280 grid-institutes:grid.7497.d schema:alternateName Applied Tumor Virology, German Cancer Research Center, D-69009, Heidelberg, Germany
281 schema:name Applied Tumor Virology, German Cancer Research Center, D-69009, Heidelberg, Germany
282 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...